
Carmila S.A (CARM) | Financial Analysis & Statements
Carmila S.A. | Large-cap | Real Estate
Carmila S.A. | Large-cap | Real Estate
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
506.9M
Gross Profit
370.7M
73.12%
Operating Income
454.8M
89.71%
Net Income
314.1M
61.97%
EPS (Diluted)
€2.21
Balance Sheet Metrics
Total Assets
6.7B
Total Liabilities
3.3B
Shareholders Equity
3.4B
Debt to Equity
0.97
Cash Flow Metrics
Operating Cash Flow
247.6M
Free Cash Flow
293.2M
Revenue & Profitability Trend
Carmila S.A Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 506.9M | 462.0M | 445.8M | 429.5M | 429.4M |
Cost of Goods Sold | 136.3M | 119.6M | 110.6M | 139.6M | 158.5M |
Gross Profit | 370.7M | 342.4M | 335.2M | 289.9M | 270.8M |
Operating Expenses | 35.2M | 30.8M | 30.6M | 76.8M | 74.4M |
Operating Income | 454.8M | 288.4M | 288.7M | 235.8M | 214.7M |
Pre-tax Income | 315.8M | 9.5M | 222.1M | 160.5M | -198.5M |
Income Tax | 1.6M | 6.7M | 2.5M | -31.8M | -196.0K |
Net Income | 314.1M | 2.7M | 219.7M | 192.3M | -198.3M |
EPS (Diluted) | €2.21 | €0.02 | €1.52 | €1.33 | -€1.42 |
Income Statement Trend
Carmila S.A Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | 344.8M | 1.0B | 537.5M | 404.2M | 555.2M |
Non-Current Assets | 6.4B | 5.7B | 6.0B | 6.0B | 5.9B |
Total Assets | 6.7B | 6.7B | 6.5B | 6.4B | 6.5B |
Liabilities | |||||
Current Liabilities | 283.4M | 734.0M | 240.9M | 379.8M | 521.6M |
Non-Current Liabilities | 3.0B | 2.7B | 2.8B | 2.6B | 2.7B |
Total Liabilities | 3.3B | 3.4B | 3.0B | 3.0B | 3.2B |
Equity | |||||
Total Shareholders Equity | 3.4B | 3.3B | 3.5B | 3.4B | 3.3B |
Balance Sheet Composition
Carmila S.A Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 314.1M | 2.7M | 219.7M | 192.3M | -198.3M |
Operating Cash Flow | 247.6M | 66.0M | 309.3M | 281.2M | 168.3M |
Investing Activities | |||||
Capital Expenditures | 14.1M | -14.5M | -25.0M | -85.8M | -950.0K |
Investing Cash Flow | -158.3M | -14.5M | -34.2M | -171.1M | 4.0M |
Financing Activities | |||||
Dividends Paid | -170.7M | -166.7M | -143.6M | -94.5M | -73.1M |
Financing Cash Flow | -651.2M | 254.0M | -170.9M | -126.0M | 97.8M |
Free Cash Flow | 293.2M | 261.6M | 297.3M | 172.1M | 167.1M |
Cash Flow Trend
Carmila S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
7.51
Forward P/E
9.38
Price to Book
0.69
Price to Sales
4.45
PEG Ratio
9.38
Profitability Ratios
Profit Margin
59.74%
Operating Margin
58.11%
Return on Equity
9.36%
Return on Assets
2.86%
Financial Health
Current Ratio
1.22
Debt to Equity
80.62
Beta
1.54
Per Share Data
EPS (TTM)
€2.21
Book Value per Share
€24.17
Revenue per Share
€3.70
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
carm | 2.3B | 7.51 | 0.69 | 9.36% | 59.74% | 80.62 |
Compagnie du | 6.4B | 150.00 | 1.18 | 0.76% | 128.75% | 0.73 |
Covivio S.A | 5.7B | 81.59 | 0.69 | 1.65% | 6.09% | 90.76 |
Pluxee NV | 2.7B | 16.24 | 8.46 | 69.29% | 13.10% | 305.61 |
Medincell S.A | 565.5M | -18.81 | - | 61.33% | -66.50% | -1.44 |
Valneva SE | 409.5M | 70.64 | 2.11 | -44.11% | -43.21% | 120.48 |
Financial data is updated regularly. All figures are in the company's reporting currency.